Examination Report |
1 | Additional Representation Sheet | 19 Mar 2010 |
1 | TM-1 | 19 Mar 2010 |
10 | Journal Copy | 17 Jun 2015 |
11 | Returned Notices / Correspondences | 26 Dec 2019 |
12 | TM-R(RENEWAL OF TRADE MARK) | 13 Mar 2020 |
2 | Additional Representation Sheet | 19 Mar 2010 |
2 | TM-1 | 19 Mar 2010 |
3 | Examination Report | 29 Jan 2011 |
4 | Correspondence | 08 Mar 2013 |
5 | Affidavit | 11 Sep 2014 |
6 | Hearing Notice | 15 Sep 2014 |
6 | Note Sheet | 15 Sep 2014 |
7 | Hearing Notice | 15 Sep 2014 |
7 | Note Sheet | 15 Sep 2014 |
8 | Order | 30 Sep 2014 |
9 | Certificate | 17 Jun 2015 |
1 | O3 NOTICE | 9381423 | 4615508 | 10 Dec 2019 |
2 | RENEWAL INTIMATION LETTER | 9964067 | 28 Mar 2020 |
The application for Vaxafe was made on 19 March 2010.
The trademark applicant for Vaxafe is ATRIMED PHARMACEUTICALS.
Vaxafe is applied in class(es) 5.
Application for Vaxafe is on Registered stage.
Application Id allotted to Vaxafe is 1938849.
Trademark agent or attorney for the application is Lega Apex.
Vaxafe filed with the Intellectual property office as a DEVICE.